COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D Goldman, Philip C Robinson, Thomas S Uldrick, Per Ljungman
Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002630; DOI: 10.1136/jitc-2021-002630